Pharmacist’s difficult journey through the healthcare system

The journey through the Australian healthcare system has been long and hard for this pharmacist patient with Hypermobile Ehlers-Danlos syndrome.

Making antidepressant tapering safer and easier

In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.

Preparing for the 2026 intranasal flu vaccine roll out

Half of Australia has funded the roll out of the intranasal influenza vaccine, Flumist in 2026. Here's what pharmacists need to know.

Stepping down safely: deprescribing gabapentinoids in practice

Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.

These are the reasons people misuse prescription opioids

Contrary to the belief that people who misuse prescription opioids are doing the wrong thing, a recent Australian study has shown most people overuse opioids to manage symptoms such as pain and mental health conditions.

New asthma guidelines released

Pharmacists are asked to lead the shift from reliever to inhaled corticosteroid regimens and to minimise use of oral corticosteroids.